Family Medicine · Crookston, MN
NPI
1033216817
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
400 S Minnesota St
Crookston, MN, 56716
Phone (218) 281-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
937 services
Medicare patients, 2024
231
Average age 74
Drug cost, 2024
$555K
11,205 prescriptions
Company payments, 2025
$17.26
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rose B Brandt was code 99214 (office e&m - established), 316 times for 172 patients. In total Rose B Brandt billed 937 services in 30 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 316 | 172 | $56.46 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 184 | 100 | $10.98 | $2,021 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 123 | 123 | $126.21 | $16K |
| 99215 Office E&M - Established | Office | 66 | 45 | $86.39 | $5,702 |
| 99213 Office E&M - Established | Office | 51 | 43 | $35.23 | $1,797 |
| 99308 SNF E&M | Office | 20 | 13 | $49.74 | $995 |
| 99309 SNF E&M | Office | 18 | 12 | $77.79 | $1,400 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 17 | 13 | $23.48 | $399 |
| 11721 Nail Procedure | Office | 13 | 11 | $17.68 | $230 |
By year: 2022 $56K for 1,247 services; 2023 $50K for 709 services; 2024 $50K for 937 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 12 | $2.81 | $42.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Rose B Brandt prescribed most often to Medicare patients was Atorvastatin Calcium, with 608 prescriptions and refills. In total Rose B Brandt wrote 11,205 Medicare prescriptions that cost $555K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 608 | 1,060 | 95 | $6,901 |
| Losartan Potassium Generic | 404 | 635 | 52 | $3,281 |
| Lisinopril Generic | 386 | 645 | 62 | $2,321 |
| Simvastatin Generic | 361 | 723 | 65 | $2,613 |
| Amlodipine Besylate Generic | 340 | 550 | 45 | $2,038 |
| Levothyroxine Sodium Generic | 334 | 563 | 47 | $2,675 |
| Gabapentin Generic | 281 | 346 | 46 | $4,491 |
| Metoprolol Succinate Generic | 267 | 444 | 40 | $3,200 |
| Omeprazole Generic | 261 | 435 | 48 | $3,118 |
| Furosemide Generic | 247 | 347 | 40 | $1,437 |
| Pantoprazole Sodium Generic | 215 | 283 | 24 | $2,816 |
| Metoprolol Tartrate Generic | 209 | 375 | 34 | $1,722 |
| Sertraline Hcl Generic | 205 | 312 | 28 | $2,080 |
| Donepezil Hcl Generic | 191 | 209 | 18 | $2,078 |
| Hydrochlorothiazide Generic | 176 | 306 | 31 | $656 |
Brand drugs: 1,158 claims; generic drugs: 9,956 claims; opioid claims: 491.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rose B Brandt $17.26 ($17.26 in general payments such as food, travel and fees) from 1 company. The largest payer was Collegium Pharmaceutical, Inc. with $17.26.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 1 | $17.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.